ORLANDO, FLORIDA / ACCESS Newswire / October 30, 2025 / RedChip Companies will host an investor webinar with Connect Biopharma Holdings Limited (Nasdaq:CNTB) (Connect Biopharma, Connect or the Company ...
COPD emerged as an umbrella term for several respiratory diseases, including emphysema and chronic bronchitis, caused by lung damage. Because its effects are irreversible, early diagnosis and ...
Luscii's Jonathan Lewis shares how live patient data, integrated into shared care and population health, could unlock ...
ORLANDO, FLORIDA / ACCESS Newswire / October 30, 2025 / RedChip Companies will host an investor webinar with Connect Biopharma Holdings Limited (Nasdaq:CNTB) (Connect Biopharma, Connect or the Company ...
Today's call will feature prepared comments by Will Lewis, Chair and Chief Executive Officer; Roger Adsett, Chief Operating Officer; and Sara Bonstein, Chief Financial Officer. After their comments, ...
Discusses Innovations in Inhaled Treprostinil Therapies and Updates on Drug Delivery Technologies October 28, 2025 2:00 ...
November marks COPD Awareness Month, and advocates this year will focus on action, and education about chronic obstructive ...
For patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) admitted to the intensive care unit ...
Anti-IL5 therapy significantly reduces moderate and severe exacerbations in asthma and COPD, preventing major ...
In bronchiectasis, highly symptomatic patients have a greater risk of exacerbations and may benefit from long-term macrolide treatment.
Patients with obesity and asthma who used GLP-1 receptor agonists had significantly fewer exacerbations and prednisone use ...
NCR, hospitals are seeing a surge in the number of patients with complaints of throat irritation, worsening of existing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback